7.56

1.82% -0.14

Leonabio Inc (LONA)

Overview News Price History Discussions Forecast

Leonabio Inc stock is traded at $7.56, with a volume of 14,230. It is down -1.82% in the last 24 hours and down -1.31% over the past month. LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Previous Close:

$7.70

Open:

$7.9245

24h Volume:

14,230

Relative Volume:

0.37

Market Cap:

$71.23M

Revenue:

Net Income/Loss:

$-129.41M

P/E Ratio:

-0.3138

EPS:

-24.0922

Net Cash Flow:

$-51.97M

1W Performance:

-4.79%

1M Performance:

-1.31%

6M Performance:

+26.42%

1Y Performance:

+0.00%

1-Day Range:

$7.4394

$7.9245

1-Week Range:

$7.4394

$8.40

52-Week Range:

$4.21

$14.21

Leonabio Inc Stock (LONA) Company Profile

Name

Leonabio Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(425) 620-8501

Address

18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL

Employee

Twitter

Next Earnings Date

2026-08-20

Latest SEC Filings

LONA's Discussions on Twitter

Compare LONA vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LONA Leonabio Inc	7.56	72.55M	0	-129.41M	-51.97M	-24.09
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Leonabio Inc Stock (LONA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-26	Initiated	Cantor Fitzgerald	Overweight
Feb-19-26	Upgrade	Mizuho	Neutral → Outperform
Sep-19-24	Downgrade	Mizuho	Outperform → Neutral
Sep-04-24	Downgrade	BTIG Research	Buy → Neutral
Sep-04-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Sep-04-24	Downgrade	Rodman & Renshaw	Buy → Neutral
Aug-19-24	Initiated	Rodman & Renshaw	Buy
Oct-17-22	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Jul-07-22	Initiated	Mizuho	Buy
Jun-23-22	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-23-22	Downgrade	Jefferies	Buy → Hold
Jun-23-22	Downgrade	Stifel	Buy → Hold
May-10-22	Initiated	BTIG Research	Buy
Apr-21-22	Initiated	Berenberg	Buy
Dec-15-21	Initiated	Goldman	Neutral
Oct-13-20	Initiated	Goldman	Buy
Oct-13-20	Initiated	JMP Securities	Mkt Outperform
Oct-13-20	Initiated	Jefferies	Buy
Oct-13-20	Initiated	Stifel	Buy

View All

Leonabio Inc Stock (LONA) Latest News

Aug 19, 2026

LONA Maintained by Mizuho -- Price Target Lowered to $15.00 - GuruFocus

Aug 19, 2026

Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com Nigeria

Aug 19, 2026

LeonaBio (LONA) Market Close: Closes 3.19% Higher at $7.96 at the Close; Level Check: the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotLow Volatility Picks - Vinanet

Aug 18, 2026

Aug 17, 2026

LeonaBio price target lowered to $17 from $18 at Citizens - TipRanks

Aug 17, 2026